Joseph P. Lucia & Associates, LLC Biogen Inc. Transaction History

Joseph P. Lucia & Associates, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 04, 2022	SELL	$223.92 - $287.77 $10,300 - $13,237	-46 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$236.26 - $355.63 $10,867 - $16,358	46 New	46 $11,000
Q3 2020 Oct 20, 2020	SELL	$264.77 - $305.71 $12,179 - $14,062	-46 Closed	0 $0
Q1 2020 Apr 22, 2020	BUY	$268.85 - $341.04 $12,367 - $15,687	46 New	46 $15,000

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Joseph P. Lucia & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Joseph P. Lucia & Associates, LLC with notifications on news.